Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
- 25 February 2005
- journal article
- Published by Elsevier in Hepatology Research
- Vol. 31 (2) , 88-94
- https://doi.org/10.1016/j.hepres.2004.12.004
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: